Uses of antibodies directed against amyloid-β

US9676843B2 · kind B2 · utility

Assignee

• PROBIODRUG AG · DE

Inventors

• Hans-Ulrich Demuth · Halle (Saale), DE
• Stephan Schilling · Halle (Saale), DE
• Martin Kleinschmidt · Halle (Saale), DE
• Kathrin Gnoth · Halle (Saale), DE
• Anita Reisenauer-Schaupp · Bad Wurzach, DE
• Jens-Ulrich Rahfeld · Lieskau, DE
• Sonja Kampfer · Germering, DE

Key dates

• Filing date: Sep 3, 2015
• Grant date: Jun 13, 2017
• Expiry date: Sep 3, 2035

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/387
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Diagnostic assays for the diagnosis of amyloidosis, in particular Alzheimer's disease, and related aspects. In particular, monoclonal antibodies and an antibody assay are provided.